Skip to main content
. 2014 Jun 17;111(4):689–695. doi: 10.1038/bjc.2014.327

Table 3. Relationship between pSrc-Y416 and molecular biomarkers.

Variables All cases, n (%) pSrcY416 (+), n (%) pSrcY416 (−), n (%) *P-value
Number
278 (100)
105 (37.8)
173 (62.2)
 
HR status
Positive 150 (54) 51 (53.1 99 (57.6)  
Negative 118 (42.4) 45 (46.9) 73 (42.4) 0.483
Unknown
10 (3.6)
 
 
 
p53
<20% 174 (62.6) 56 (56.6) 118 (72.4)  
⩾20% 88 (31.7) 43 (43.4) 45 (27.6) 0.009
Unknown
16 (5.8)
 
 
 
Ki67
<14% 95 (34.2) 32 (33) 63 (40.1)  
⩾14% 159 (57.2) 65 (67) 94 (59.9) 0.253
Unknown
24 (8.6)
 
 
 
PTEN
Loss 47 (16.9) 15 (14.9) 32 (18.9)  
Present 224 (80.6) 87 (85.3) 137 (81.1) 0.373
Unknown
7 (2.5)
 
 
 
α-IGF1R
No overexpression 191 (68.7) 69 (67) 122 (74.8)  
Overexpression 75 (27) 34 (33) 41 (25.2) 0.165
Unknown
12 (4.3)
 
 
 
EGFR
Negative 221 (79.5) 93 (92.1) 128 (79.5)  
Positive 41 (14.7) 8 (7.9) 33 (20.5) 0.006
Unknown
16 (5.8)
 
 
 
PIK3CA mut
Negative 201 (72.3) 78 (86.7) 123 (80.4)  
Positive 42 (15.1) 12 (13.3) 30 (19.6) 0.212
Unknown
35 (12.6)
 
 
 
p110α
No overexpression 186 (66.9) 64 (77.1) 122 (85.3)  
Overexpression 40 (14.4) 19 (22.9) 21 (14.7) 0.119
Unknown
52 (18.7)
 
 
 
pAkt
No overexpression 186 (66.9) 63 (71.6) 123 (77.8)  
Overexpression 60 (21.6) 25 (28.4) 35 (22.2) 0.273
UNKNOWN
32 (11.5)
 
 
 
p-mTOR
No overexpression 161 (57.9) 58 (56.9) 103 (62.4)  
Overexpression 106 (38.1) 44 (43.1) 62 (37.6) 0.367
Unknown
11 (4)
 
 
 
pMAPK
No overexpression 203 (73) 61 (74.4) 142 (92.8)  
Overexpression 32 (11.5) 21 (25.6) 11 (7.2) <0.000
Unknown
43 (15.5)
 
 
 
p27
Loss 89 (32) 25 (26) 64 (39.5)  
Present 169 (60.8) 71 (74) 98 (60.5) 0.028
Unknown 20 (7.2)      

Abbreviations: EGFR=epidermal growth factor receptor; HR=hormone receptor; IGF1R=insulin-like growth factor 1-receptor.

*All comparisons by Chi2 or Fisher tests.